The Swiss pharmaceutical giant's plant will produce compounds needed for radioligand therapy (RLT), a form of precision ...

Novartis (SWX:NOVN) has seen its stock move steadily over the past month, reflecting a mix of investor sentiment and ongoing ...

A well-tolerated antisense oligonucleotide yielded significant reductions in severe hypertriglyceridemia while lowering risk for acute pancreatitis in two phase 3 trials.

The Competition Commission of Pakistan (CCP) has authorised the transaction of Standpharm Pakistan (Private) Limited by Crest ...

Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion; Avidity expects to ...

Novartis, a global innovative medicines company, has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, CA.

Cogent Biosciences' stock has soared after its lead asset, bezuclastinib plus sunitinib, outperformed sunitinib alone in a ...

The Pharmerging Market refers to the rapidly expanding pharmaceutical sectors in emerging economies, fueled by rising healthcare needs and the growing burden of chronic diseases. This market is ...

Founded in 2000 with the merger of Novartis and AstraZeneca, Syngenta proudly marks its 25th anniversary as a leading ...

CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.

"By combining precise tumour targeting with an immunotherapy payload, Daiichi Sankyo is exploring a new way to harness the ...

The acute kidney injury (AKI) treatment market is showing consistent growth, with an expected compound annual growth rate (CAGR) of around 8% over the forecast period. This growth is fueled by several ...